Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Emerging from the University of Exeter, augmented depression therapy (ADepT) proposes a novel approach in depression treatment, potentially surpassing the current gold standard, cognitive behavioral therapy (CBT), in both efficacy and cost-efficiency. This ground-breaking therapy, focusing on both symptom reduction and well-being enhancement, offers promising implications for the future of mental health care.
Psychiatry July 19th 2023
As tDCS devices gain popularity for at-home use, physicians must navigate the complex terrain of this emerging trend, balancing the devices’ potential benefits with the stark reality of unverified efficacy and potential side effects.
Neurology July 5th 2023
Pioneering research from the Malaghan Institute reveals the potential of hookworm therapy for patients in remission from ulcerative colitis, suggesting a path towards medication-free disease management—learn more about these groundbreaking findings.
Gastroenterology June 29th 2023
SingleCare
Explore how the age-old remedy of apple cider vinegar might offer modern benefits for men’s health, including weight management, blood sugar control, and cholesterol reduction.
All Specialties June 21st 2023
The New England Journal of Medicine
Decoding the Efficacy: Ketamine and ECT in the Battle Against Treatment-Resistant Depression As you delve into the comparative effectiveness of ketamine and ECT, NEJM highlights the key findings from a recent noninferiority trial that could reshape your understanding of these treatments.
Psychiatry June 6th 2023
Psychiatrist.com
The authors explore the clinical and economic evidence of the benefit of rTMS and discuss the impact of restricting access to the therapy through overly aggressive prior authorization practices.
Psychiatry May 9th 2023